<sup>18</sup>F-FDG PET and CT scans of patient before and after <sup>177</sup>Lu-3BP-227 Therapy (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

<sup>18</sup>F-FDG PET and CT scans of patient before and after <sup>177</sup>Lu-3BP-227 Therapy

Caption

(A) 18FDG PET before 177Lu-3BP-227 therapy. Red oval: primary tumor; arrows: liver metastases. (B, upper panel) Axial CT section; primary tumor (blue oval) before 177Lu-3BP-227 therapy. (B, lower panel) Axial CT section; primary tumor (blue oval) after 3 cycles of 177Lu-3BP-227 therapy. (C) 18FDG PET after 3 cycles of 177Lu-3BP-227 therapy.

Credit

RP Baum, A Singh et al., THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

Usage Restrictions

At least title and credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.